Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
InhaleRx Limited ( (AU:IRX) ) has shared an announcement.
InhaleRx Limited’s latest quarterly cash flow report reveals a net cash outflow from operating activities amounting to $310,000, despite receiving $489,000 in government grants and tax incentives. The company also secured $247,000 from financing activities, leading to an overall increase in cash and cash equivalents by $480,000 for the period. This financial update highlights the company’s reliance on external funding and government support to sustain its operations, which may impact its strategic positioning and stakeholder confidence.
More about InhaleRx Limited
InhaleRx Limited operates in the healthcare industry, focusing on the development and commercialization of inhalation therapies. The company is primarily engaged in research and development, product manufacturing, and marketing of its inhalation products.
Average Trading Volume: 152,017
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$7.19M
For a thorough assessment of IRX stock, go to TipRanks’ Stock Analysis page.